4.4 Review

Zinc as a marker of affective disorders

Journal

PHARMACOLOGICAL REPORTS
Volume 65, Issue 6, Pages 1512-1518

Publisher

POLISH ACAD SCIENCES INST PHARMACOLOGY
DOI: 10.1016/S1734-1140(13)71512-3

Keywords

zinc; marker; depression; affective disorders

Funding

  1. [POIG 01.01.02-12-004/09]

Ask authors/readers for more resources

Depression is considered as a chronic and recurring illness with functional impairment, significant disability, morbidity and mortality. Despite the extensive research carried out on depression, its pathophysiology is still poorly understood. An important problem concerning research into depressive disorder is the lack of biological markers which could improve diagnosis or indicate a risk of developing depression or risk of relapse. Several reports indicated decreased zinc concentrations and even its deficit in clinical depression, so the measurement of the concentration of this element in the blood of patients was suggested as a useful and specific clinical marker of depression. The reported results indicated that the serum zinc level might be a marker of depression as a state (state marker) in treatment responsive patients. However, in drug-resistant depression a decreased concentration of zinc may be a marker of traits (trait marker). It seems, however, that the measurement of the concentrations of zinc might be in the future a component of the battery of tests; of markers of immune activation and oxidative stress rather than itself alone.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression

Monika Marcinkowska, Barbara Mordyl, Nikola Fajkis-Zajaczkowska, Agata Siwek, Tadeusz Karcz, Alicja Gawalska, Adam Bucki, Pawel Zmudzki, Anna Partyka, Magdalena Jastrzebska-Wiesek, Bartosz Pomierny, Maria Walczak, Magdalena Smolik, Karolina Pytka, Kamil Mika, Magdalena Kotanskad, Marcin Kolaczkowski

Summary: There is evidence showing that the combination of GABA molecule and chemical fragments interacting with the serotonin 5-HT6 receptor can curb neuroinflammation and provide antidepressant-like activity. The hybrid molecule 3B has shown promising affinity for 5-HT6 receptors and agonistic properties on GABA-A receptors. In vivo studies have demonstrated its robust antidepressant-like activity and effectiveness in reducing oxidative stress markers and the pro-inflammatory cytokine IL-6.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Cell Biology

Anti-inflammatory effects of new human histamine H3 receptor ligands with flavonoid structure on BV-2 neuroinflammation

Ewelina Honkisz-Orzechowska, Katarzyna Popiolek-Barczyk, Zuzanna Linart, Jadwiga Filipek-Gorzala, Anna Rudnicka, Agata Siwek, Tobias Werner, Holger Stark, Jakub Chwastek, Katarzyna Starowicz, Katarzyna Kiec-Kononowicz, Dorota Lazewska

Summary: This study demonstrates the strong anti-inflammatory effect of new human H3R ligands with flavonoid structure in murine microglial cells. Further research is needed to understand the mechanism of action of flavonoids in reducing inflammation.

INFLAMMATION RESEARCH (2023)

Article Engineering, Electrical & Electronic

Is the hypersensitivity to electromagnetic fields caused by a physical mechanism or is it a psychological problem?

Grzegorz Taton, Artur Kacprzyk, Tomasz Rok, Anna Wasik, Marcin Siwek

Summary: In recent years, studies have been conducted on the impact of electromagnetic field (EMF) on humans, particularly focusing on electromagnetic hypersensitivity (EHS) in Poland and the characterization of individuals affected by this syndrome. Some researchers argue that EHS is not caused by the actual physical effects of EMF, but rather by psychological mechanisms. This paper provides an overview of three research projects that support this claim.

PRZEGLAD ELEKTROTECHNICZNY (2023)

Article Oncology

Bipolar spectrum in prostate cancer patients and its role in stress related symptoms

Adrian Andrzej Chrobak, Mikolaj Przydacz, Marcin Chlosta, Karolina Machalska, Aleksander Turek, Maja Popiol, Michal Skalski, Aleksandra Arciszewska-Leszczuk, Piotr Chlosta, Marcin Siwek, Dominika Dudek

Summary: This study aimed to evaluate bipolar spectrum symptoms in prostate cancer patients and establish their possible associations with stress related symptoms during diagnosis and treatment. Results showed that prostate cancer patients had higher HCL-32 scores compared to healthy individuals, and the symptoms were associated with more severe stress related to prostate cancer reflected by higher scores on IES-R and its subscales (Avoidance, Intrusions, and Hyperarousal).

PSYCHO-ONCOLOGY (2023)

Article Cell Biology

Dietary Zinc Differentially Regulates the Effects of the GPR39 Receptor Agonist, TC-G 1008, in the Maximal Electroshock Seizure Test and Pentylenetetrazole-Kindling Model of Epilepsy

Urszula Doboszewska, Katarzyna Socala, Mateusz Pierog, Dorota Nieoczym, Jan Sawicki, Adam Sajnog, Bernadeta Szewczyk, Katarzyna Mlyniec, Ireneusz Sowa, Danuta Baralkiewicz, Piotr Wlaz

Summary: The G-protein coupled receptor 39 (GPR39) is a potential target for future drugs, and its pharmacology is not fully understood. Zinc acts as an endogenous agonist or an allosteric modulator for GPR39, while TC-G 1008 is a synthetic agonist. Zinc also enhances the activity of TC-G 1008 at GPR39. Activation of GPR39 by TC-G 1008 promotes epileptogenesis in an epilepsy model and decreases seizure threshold in a seizure test. The amount of zinc in the diet contributes to the effects of TC-G 1008 in vivo.

CELLS (2023)

Article Neurosciences

TED-Trazodone Efficacy in Depression: A Naturalistic Study on the Efficacy of Trazodone in an Extended-Release Formulation Compared to SSRIs in Patients with a Depressive Episode-Preliminary Report

Marcin Siwek, Aleksandra Gorostowicz, Adrian Andrzej Chrobak, Adrian Gerlich, Anna Julia Krupa, Andrzej Juryk, Dominika Dudek

Summary: These preliminary results report the findings of a 12-week study that compared the effectiveness of trazodone XR and SSRIs in treating MDD. The study showed that trazodone XR was more effective than SSRIs in reducing the severity of insomnia and depression.

BRAIN SCIENCES (2023)

Article Biochemistry & Molecular Biology

Dual Molecules Targeting 5-HT6 and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation

Monika Marcinkowska, Barbara Mordyl, Agata Siwek, Monika Gluch-Lutwin, Tadeusz Karcz, Alicja Gawalska, Michal Sapa, Adam Bucki, Katarzyna Szafranska, Bartosz Pomierny, Karolina Pytka, Magdalena Kotanska, Kamil Mika, Marcin Kolaczkowski

Summary: In this study, a set of dually acting molecules were designed to modulate GABA-A and 5-HT6 receptor activity simultaneously, aiming to improve therapeutic outcomes in treatment-resistant depression. Lead molecule 16 showed desirable receptor profile and physicochemical properties, reducing proinflammatory cytokine secretion and oxidative stress markers. Animal studies demonstrated antidepressant-like activity of 16 through synergic interplay between 5-HT6 and GABA-A receptors. These findings suggest that hybrid molecule 16 is an interesting tool that interacts with pharmacologically relevant targets, matching the pathological dysfunction of depression associated with neuroinflammation.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

2-(4-Fluorophenyl)-1H-benzo[d]imidazole as a Promising Template for the Development of Metabolically Robust, α1β2γ2GABA-A Receptor-Positive Allosteric Modulators

Monika Marcinkowska, Nikola Fajkis-Zajaczkowska, Katarzyna Szafranska, Jakub Jonczyk, Agata Siwek, Barbara Mordyl, Tadeusz Karcz, Gniewomir Latacz, Marcin Kolaczkowski

Summary: Modulating the alpha 1 beta 2 gamma 2 GABA-A receptor subpopulation in the basal ganglia region is a promising pharmacological strategy for neurological dysfunction. However, the current chemical space of molecules targeting the alpha 1/gamma 2 interface of GABA-A receptors is limited. In this study, we identified a series of 2-(4-fluorophenyl)-1H-benzo-[d]imidazoles as positive allosteric modulators (PAMs) with improved stability and reduced hepatotoxicity. These PAMs showed preference for interaction with the alpha 1/gamma 2 interface of the GABA-A receptor, providing useful chemical templates for further exploration of therapeutic potential.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Pharmacology & Pharmacy

The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission

Gabriela Starowicz, Dominika Siodlak, Gabriel Nowak, Katarzyna Mlyniec

Summary: This study aimed to investigate the role of glutamatergic and GABAergic system activation in TC-G 1008 antidepressant-like effects and the disruptions caused by a low-zinc diet. The results showed that the antidepressant-like effect of TC-G 1008 was blocked by NMDA and picrotoxin, and joint administration with muscimol or SCH50911 showed a trend towards decreased immobility time. A zinc-deficient diet resulted in dysregulation of GluN1, PSD95, and KCC2 protein expression. These findings suggest the important role of glutamate/GABA signaling in the antidepressant-like effect of TC-G 1008 and imply that GPR39 may be a novel target for the development of antidepressants.

PHARMACOLOGICAL REPORTS (2023)

Review Neurosciences

Brexpiprazole-Pharmacologic Properties and Use in Schizophrenia and Mood Disorders

Marcin Siwek, Krzysztof Wojtasik-Bakalarz, Anna Julia Krupa, Adrian Andrzej Chrobak

Summary: The first III generation antipsychotic drug, aripiprazole, was registered in 2002. It has a unique mechanism of action and potentially beneficial influence on symptoms of schizophrenia. However, it can cause agitation, anxiety, or akathisia. Brexpiprazole, registered in 2015, was developed to retain the positive actions of aripiprazole while presenting a better clinical profile. It shows promise in treating symptoms that previous antipsychotics were not sufficiently effective in, including negative, depressive, or cognitive symptoms.

BRAIN SCIENCES (2023)

Editorial Material Neurosciences

Psychopharmacology and Biological Studies of Psychosis

Marcin Siwek, Bernadeta Szewczyk, Adrian Andrzej Chrobak

BRAIN SCIENCES (2023)

Article Pharmacology & Pharmacy

TED-trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder

Dominika Dudek, Adrian Andrzej Chrobak, Anna Julia Krupa, Aleksandra Gorostowicz, Adrian Gerlich, Andrzej Juryk, Marcin Siwek

Summary: This study aimed to compare the effectiveness and tolerability of SSRIs and trazodone XR in treating MDD. The results showed that trazodone XR was more effective than SSRIs in reducing the severity of depression, anxiety, and insomnia. It also showed potential superiority in reducing anhedonia.

FRONTIERS IN PHARMACOLOGY (2023)

Article Psychiatry

Depression, anxiety, insomnia and interleukins in the early postpartum period

Ewa Drozdowicz-Jastrzebska, Anna Mach, Michal Skalski, Piotr Januszko, Zoulikha Jabiry-Zieniewicz, Marcin Siwek, Zbigniew Maciej Wawrzyniak, Maria Radziwon-Zaleska

Summary: This study found a relationship between anxiety, insomnia, and postpartum depression. Assessing anxiety symptoms and sleep quality is important in screening women at risk of postpartum depression. Additionally, divorced and single women were shown to be at higher risk of postpartum depression.

FRONTIERS IN PSYCHIATRY (2023)

Article Psychiatry

When practice does not make a perfect - paradoxical learning curve in schizophrenia and bipolar disorder revealed by different serial reaction time task variants

Adrian Andrzej Chrobak, Katarzyna Siuda-Krzywicka, Zbigniew Soltys, Sylwia Bielak, Dominik Nowaczek, Aleksandra Zyrkowska, Magdalena Fafrowicz, Tadeusz Marek, Ewa Pecherzewska, Jan Kuzdzal, Anna Starowicz-Filip, Aleksandra Gorostowicz, Dominika Dudek, Marcin Siwek

Summary: This study aimed to verify previously observed deficits in implicit motor learning in schizophrenia and bipolar disorder patients. Results showed that both clinical groups presented decreased indices of implicit motor learning compared to healthy controls, with a paradoxical learning pattern. The new limited response time SRTT variant replicated the findings of disrupted implicit motor learning in SZ and BD.

FRONTIERS IN PSYCHIATRY (2023)

Article Psychiatry

Polish adaptation of the Dimensional Anhedonia Rating Scale (DARS) - validation in the clinical sample

Aleksandra Gorostowicz, Sakina J. Rizvi, Sidney H. Kennedy, Adrian Andrzej Chrobak, Dominika Dudek, Katarzyna Cyranka, Joanna Piekarska, Eve Krawczyk, Marcin Siwek

Summary: The aim of this study was to validate the Polish adaptation of the Dimensional Anhedonia Rating Scale (DARS) in patients with mood disorders and healthy controls. The results showed that the Polish DARS had excellent internal consistency and very good validity, making it a valuable tool for measuring anhedonia in patients with mood disorders.

FRONTIERS IN PSYCHIATRY (2023)

No Data Available